
Government caps trade margins on 137 anti-cancer drugs at 30%
The story in brief
The government has capped trade margins on 137 anti-cancer drugs at 30%, with manufacturers required to maintain current production levels. Prices are calculated using a formula including trade margin and GST, effective from 09.11.2026. Experts note that even with rationalisation, patented medicines remain unaffordable for many.